DOI:
10.1055/s-00031934
The Journal of Hip Surgery
LinksClose Window
References
Raje N, Terpos E, Willenbacher W. , et al.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol 2018;
19 (03) 370-381
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.